However, when spleen cells from vaccinated tumor bearing mice were stimulated with mCAR12/mCDK12 in the presence of the anti-TIGIT antagonist antibody, more CD4 and CD8 T cells produced IFN-γ as assessed by flow cytometry (Figure 3C). This evidence concerns the gene TIGIT and neoplasm.